These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7205124)

  • 1. Biological half-life and organ distribution of [3H]1-deamino-8-D-arginine-vasopressin in the rat.
    László FA; Janáky T; Baláspiri L; Morgat JL
    J Endocrinol; 1981 Feb; 88(2):181-6. PubMed ID: 7205124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological half-lives and organ distribution of tritiated 8-lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin in Brattleboro rats.
    Janáky T; Laczi F; László FA
    Ann N Y Acad Sci; 1982; 394():116-27. PubMed ID: 6960751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological half-life and organ distribution of [3H]8-arginine-vasopressin in the rat.
    Janáky T; László FA; Sirokmán F; Morgat JL
    J Endocrinol; 1982 Jun; 93(3):295-303. PubMed ID: 7086324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tritiation of vasopressin analogues and their metabolic fate after intravenous injection in the rat.
    Janáky T; László FA; Morgat JL
    Acta Med Hung; 1984; 41(1):43-54. PubMed ID: 6739223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological half-life and organ distribution of [3H]8-arginine vasopressin following administration of vasopressin receptor antagonist OPC-31260.
    Molnár AH; Varga C; Janáky T; Tóth G; Tóth G; Farkas J; László F; László FA
    Regul Pept; 2007 Jun; 141(1-3):12-8. PubMed ID: 17258819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of thirsting on biological half-life and organ distribution of 3H-dDAVP in rat.
    Janáky T; László FA; Baláspiri L; Morgat JL
    Horm Metab Res; 1982 Jul; 14(7):385-6. PubMed ID: 7118063
    [No Abstract]   [Full Text] [Related]  

  • 7. DDAVP (1-desamino-8-D-arginine vasopressin) clearance rate.
    Stegner H; Artman HG; Leake RD; Fisher DA
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):204-6. PubMed ID: 6495988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of 1-desamino-8-D-arginine vasopressin (DDAVP) in patients with central diabetes insipidus.
    Pullan PT; Burger HG; Johnston CI
    Clin Endocrinol (Oxf); 1978 Sep; 9(3):273-8. PubMed ID: 709897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of [mercaptopropionic acid1, D-arginine8]-vasopressin (dDAVP) in pancreatic juice and intestinal mucosa homogenate.
    Lundin S; Bengtsson HI; Folkesson HG; Weström BR
    Pharmacol Toxicol; 1989 Aug; 65(2):92-5. PubMed ID: 2813288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoradiographic localization of 3H-dDAVP in the rat kidney.
    László FA; Morgat JL; Halász N; Joó F
    Horm Metab Res; 1981 Aug; 13(8):474-5. PubMed ID: 7327529
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of arginine-8-vasopressin and 1-deamino-8-D-arginine-vasopressin on ACTH secretion in rats.
    László FA; Janáky T; Julesz J; Kárteszi M; Makara GB; Stark E
    Endocrinol Exp; 1983 Jun; 17(2):133-6. PubMed ID: 6309504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.
    Manning M; Balaspiri L; Moehring J; Haldar J; Sawyer WH
    J Med Chem; 1976 Jun; 19(6):842-5. PubMed ID: 950656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of arginine vasopressin receptors in the rat testis.
    Meidan R; Hsueh AJ
    Endocrinology; 1985 Jan; 116(1):416-23. PubMed ID: 2981073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impermeability of the blood-cerebrospinal fluid barrier to 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with acquired, communicating hydrocephalus.
    Sørensen PS; Vilhardt H; Gjerris F; Warberg J
    Eur J Clin Invest; 1984 Dec; 14(6):435-9. PubMed ID: 6441719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of infused arginine-vasopressin and its long-acting deaminated analogue in rats.
    Gazis D; Sawyer WH
    J Endocrinol; 1978 Aug; 78(2):179-86. PubMed ID: 702013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of vasopressin and determination of its corticomedullary levels in rat kidney tissue.
    Shimizu K; Nakao A; Nonaka T; Oka H
    Kidney Int; 1984 Dec; 26(6):785-90. PubMed ID: 6533393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
    Walker LA; Frölich JC
    J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of 1-deamino-8-D-arginine vasopressin after intragastric administration in the rat.
    Lundin S; Melin P; Vilhardt H
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):179-83. PubMed ID: 3969814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor.
    Saito M; Tahara A; Sugimoto T
    Biochem Pharmacol; 1997 Jun; 53(11):1711-7. PubMed ID: 9264324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP).
    Yamaguchi Y; Yamada K; Suzuki T; Wu YP; Kita K; Takahashi S; Ichinose M; Suzuki N
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E970-6. PubMed ID: 15198931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.